XML 38 R3.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Statements of Operations - USD ($)
$ in Millions
 12 Months Ended
Feb. 03, 2024
Jan. 28, 2023
Jan. 29, 2022
Total revenue $ 107,412 $ 109,120 $ 106,005
Cost of sales 77,736 82,229 74,963
Selling, general and administrative expenses 21,554 20,658 19,752
Depreciation and amortization (exclusive of depreciation included in cost of sales) 2,415 2,385 2,344
Operating income 5,707 3,848 8,946
Net interest expense 502 478 421
Net other income (92) (48) (382)
Earnings before income taxes 5,297 3,418 8,907
Provision for income taxes 1,159 638 1,961
Net earnings $ 4,138 $ 2,780 $ 6,946
Basic earnings per share (in usd per share) $ 8.96 $ 6.02 $ 14.23
Diluted earnings per share (in usd per share) $ 8.94 $ 5.98 $ 14.10
Weighted average common shares outstanding      
Basic (in shares) 461,500,000 462,100,000 488,100,000
Diluted (in shares) 462,800,000 464,700,000 492,700,000
Antidilutive shares (in shares) 2,100,000 1,100,000 0
Sales      
Total revenue $ 105,803 $ 107,588 $ 104,611
Other revenue      
Total revenue $ 1,609 $ 1,532 $ 1,394